🔎 Trials Near Me

መነሻ › ሜዱሎብላስቶማ › ፍሎሪዳ

በፍሎሪዳ ለሜዱሎብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሜዱሎብላስቶማ የሚደረጉ 6 ጥናቶች በፍሎሪዳ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በፍሎሪዳ ውስጥ ያሉ ከተሞች

Official study text (English)

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • Orlando Health Arnold Palmer Hospital for Children, Orlando
  • St. Joseph's Children's Hospital, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 2
59 Months · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT05535166

Digoxin Medulloblastoma Study

  • Nemours Jacksonville, Jacksonville
  • University of Miami, Miami
  • Johns Hopkins All Children's, St. Petersburg
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ4 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Nicklaus Children's Hospital, Miami
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • Nicklaus Children's Hospital, Miami
  • Arnold Palmer Hospital for Children, Orlando
  • All Children's Hospital Johns Hopkins Medicine, St. Petersburg
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT04696029

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

  • University of Florida Health, Gainesville
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ4 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06514898

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።